positive regulation of MHC class II biosynthetic process

Definition

Target type: biologicalprocess

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of MHC class II. [GOC:go_curators]

The positive regulation of MHC class II biosynthetic process is a complex and tightly controlled cellular process that ensures the efficient production and presentation of peptide antigens to CD4+ T cells, initiating adaptive immune responses. This process involves multiple steps, starting with the transcription of MHC class II genes and culminating in the assembly of functional MHC class II-peptide complexes on the cell surface.

**Transcriptional Regulation:**

* **Transcription factors:** Transcription factors like CIITA (Class II Transactivator) and RFX5 are essential for the transcription of MHC class II genes. CIITA is induced by interferons (IFNs) and other immune signals, while RFX5 is constitutively expressed. These factors bind to specific promoter regions in MHC class II genes, activating their transcription.
* **Signaling pathways:** Signaling pathways, such as the interferon-gamma (IFN-γ) pathway, play a crucial role in regulating CIITA expression and MHC class II gene transcription. IFN-γ, a potent immune cytokine, activates the JAK-STAT signaling pathway, leading to the induction of CIITA and increased MHC class II gene transcription.

**Assembly of MHC Class II Molecules:**

* **Synthesis and folding:** MHC class II α and β chains are synthesized separately in the endoplasmic reticulum (ER). Chaperone proteins like calnexin and calreticulin assist in their proper folding and assembly.
* **Invariant chain (Ii):** The invariant chain (Ii) associates with newly synthesized MHC class II αβ dimers in the ER. Ii acts as a chaperone, preventing premature peptide binding and guiding the complex to the endosomal compartment.
* **Transport to endosomes:** The MHC class II-Ii complex is transported from the ER to endosomes via the Golgi apparatus.
* **Ii degradation:** In endosomes, Ii is partially degraded by proteases, leaving a short peptide fragment called CLIP (Class II-associated invariant chain peptide) associated with MHC class II.

**Peptide Loading:**

* **CLIP removal:** A dedicated molecule called HLA-DM (Human leukocyte antigen-DM) binds to the MHC II-CLIP complex and facilitates the removal of CLIP.
* **Peptide binding:** After CLIP removal, the MHC II molecule is ready to bind peptides derived from intracellularly processed antigens. This process occurs in endosomes and is highly selective.
* **Transport to cell surface:** The loaded MHC II-peptide complexes are transported to the cell surface, where they can interact with CD4+ T cells, initiating antigen presentation.

**Regulation and Feedback Mechanisms:**

* **Ubiquitination and degradation:** MHC class II molecules can be ubiquitinated and targeted for degradation by the proteasome, providing a mechanism for regulating their levels and ensuring proper antigen presentation.
* **Cross-presentation:** MHC class II molecules can also be loaded with peptides derived from exogenous antigens through a process called cross-presentation, allowing the presentation of antigens from other cells.

In summary, the positive regulation of MHC class II biosynthetic process is a tightly controlled process involving transcriptional activation, chaperone-mediated folding, and efficient loading of peptide antigens in endosomes. This intricate process ensures the correct presentation of antigens to CD4+ T cells, playing a vital role in initiating and shaping adaptive immune responses.'
"

Proteins (4)

Compounds (211)